Latest filing published 21 May 2026 for Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.), €6,433.
Johnny Powers discloses dealings in Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) to SEDI. We count 38 filings; the first trade dates from 12 April 2021 and the latest from 20 May 2026.
On the open market, the record shows 26 purchases worth €264k and 3 sales worth €725k. The net balance comes to €461k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 9 option exercises. In 2026 alone, the filings show 7 purchases and no sales.
The median purchase comes to €6,360. None of the 22 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The latest filing, published on 21 May 2026, reports an open-market purchase of €6,433 in Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.). The median gap between a trade and its publication by SEDI is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 36 declarations